Steven Cohen’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.9M Buy
+15,812
New +$9.26M 0.01% 1358
2024
Q3
– Sell
-62,432
Closed -$25.7M – 2208
2024
Q2
$25.7M Buy
+62,432
New +$24.7M 0.07% 340
2023
Q4
– Sell
-146,101
Closed -$35.4M – 2547
2023
Q3
$35.4M Buy
146,101
+144,381
+8,394% +$36.9M 0.1% 259
2023
Q2
$413K Buy
+1,720
New +$357K ﹤0.01% 1297
2021
Q3
– Sell
-75,951
Closed -$13.4M – 1156
2021
Q2
$13.4M Sell
75,951
-37,439
-33% -$6.46M 0.06% 380
2021
Q1
$18.6M Buy
113,390
+54,751
+93% +$8.37M 0.09% 279
2020
Q4
$8.16M Sell
58,639
-61,222
-51% -$7.72M 0.04% 486
2020
Q3
$13.4M Buy
+119,861
New +$13.9M 0.07% 347
2019
Q2
– Sell
-8,433
Closed -$497K – 1458
2019
Q1
$497K Buy
+8,433
New +$504K ﹤0.01% 867
2018
Q4
– Sell
-18,033
Closed -$1.08M – 1119
2018
Q3
$1.08M Sell
18,033
-23,467
-57% -$1.28M ﹤0.01% 843
2018
Q2
$1.78M Buy
+41,500
New +$1.68M 0.01% 764
2017
Q3
– Sell
-154,400
Closed -$4.48M – 980
2017
Q2
$4.48M Buy
+154,400
New +$4.33M 0.03% 525

Other funds holding MEDP

Steven Cohen's MEDP Position: Q3 2026 in Review

Steven Cohen opened a new position in Medpace (MEDP) in Q3 2026: 15,812 shares worth $9.9M. The stake represents 0.01% of the portfolio and ranks #1358 among its holdings. This is a return to the name: Steven Cohen previously reported a position in MEDP as recently as Q2 2024.

Steven Cohen first reported a position in MEDP in Q2 2017 and has held it in 12 quarters since. The position peaked at $35.4M in Q3 2023. 751 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Steven Cohen held 15,812 shares of Medpace worth $9.9M as of Q3 2026.
  • Medpace was a new Steven Cohen position in Q3 2026.
  • Medpace made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1358 holding.
  • Steven Cohen first reported a position in Medpace in Q2 2017 and has held it in 12 quarters since.
  • Steven Cohen's Medpace position peaked at $35.4M in Q3 2023.
  • 751 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.